Most patients taking vitamins for macular degeneration actually don’t need them. These popular vitamins are only indicated for a specific subset of macular degeneration.
Month: July 2012
FDA DODAC recommends approval of ThromboGenics’ ocriplasmin for VMA
ThromboGenics NV, a biopharmaceutical company focused on developing innovative ophthalmic medicines, today announces that the US Food and Drug Administration (FDA) Dermatologic and Ophthalmic Drugs Advisory Committee has recommended that the FDA grant …
FDA panel endorses drug for vitreomacular adhesion
WASHINGTON (Reuters) – A Food and Drug Administration panel on Thursday recommended ThromboGenics NV’s
ocriplasmin as a treatment for vitreomacular adhesion, an aging-related vision problem that can lead to
blindness.
Ranibizumab Recommended for Diabetic Macular Edema
An advisory committee to the US Food and Drug Administration (FDA) voted to recommend ranibizumab (Lucentis, Genentech, Inc) for the treatment of diabetic macular edema. Medscape Medical News
FDA Panel Says OK to New Use for Eye Drug
WASHINGTON (MedPage Today) — An FDA advisory committee voted unanimously on Thursday to recommend approval of a new indication for ranibizumab (Lucentis) for the treatment of diabetic macular edema.
Southern England Health Authority withdraws intravitreal bevacizumab policy following legal dispute
Source: Reuters
Area: News
According to a Reuters report, the Southampton, Hampshire, Isle of Wight and Portsmouth Primary Care Trust Cluster has discontinued its policy of offering intravitreal bevacizumab, an unlicensed but cheaper treatment for th…
Southern England Health Authority withdraws intravitreal bevacizumab policy following legal dispute
Source: Reuters
Area: News
According to a Reuters report, the Southampton, Hampshire, Isle of Wight and Portsmouth Primary Care Trust Cluster has discontinued its policy of offering intravitreal bevacizumab, an unlicensed but cheaper treatment for th…
AAQ chemical temporarily restores vision in blind mice
A team of University of California, Berkeley, scientists in collaboration with researchers at the University of Munich and University of Washington in Seattle has discovered a chemical that temporarily restores some vision to blind mice, and is working…
FDA panel gives nod to drug for diabetic macular edema
Early-age cataract surgery increases central corneal thickness
When congenital cataract surgery is performed at an early age, central corneal thickness increases, show study results published in the British Journal of Ophthalmology.
FDA Panel to Mull Diabetic Eye Disease Drug
(MedPage Today) — Ranibizumab (Lucentis) helped improve vision for diabetic patients with macular edema, according to FDA reviewers, but the drug’s higher of two doses comes with more adverse events.
‘Just Because’ Now Added as Reason to Deny Claims
With apologies to The Onion, Andrew Vickers reports on a additional reason from health insurers for denying claims to patients, which should cover just about everything. Medscape Humor
Regeneron reports total revenues of $304 million for second quarter 2012
Regeneron Pharmaceuticals, Inc. today announced financial and operating results for the second quarter of 2012 and provided an update on development programs.
Targeting Therapeutics To The Back Of The Eye Using Microneedles
Thanks to tiny microneedles, eye doctors may soon have a better way to treat diseases such as macular degeneration that affect tissues in the back of the eye. That could be important as the population ages and develops more eye-related illnesses – and …
UK authority backs down in Novartis eye drug dispute
LONDON (Reuters) – A regional British health authority said on Wednesday it had decided to stop using
the cancer drug Avastin as a cheap alternative to eye medicine Lucentis following a legal challenge from Novartis,
which sells Lucentis in Eur…
FDA staff say Lucentis eases diabetic macular edema
WASHINGTON (Reuters) – U.S. drug reviewers on Tuesday said Roche Holding AG’s drug Lucentis appeared
to help patients with diabetic macular edema (DME).
Microneedles can deliver drug formulations into the eye
Thanks to tiny microneedles, eye doctors may soon have a better way to treat diseases such as macular degeneration that affect tissues in the back of the eye. That could be important as the population ages and develops more eye-related illnesses – and …
News From The Journal Of Clinical Investigation: July 23, 2012
ONCOLOGY PES1 controls a balancing act in breast cancer Estrogen signaling is known to be an important driving force in many breast cancers. Estrogen can signal through two different estrogen receptors (ERs), ERα and ERβ, but the effects that e…
Decreased Prevalence Of Blindness And Visual Impairment
The numbers of people in Germany who are blind or visually impaired is going down. Robert P. Finger and his co-authors present their findings in the current edition of Deutsches Arzteblatt International (Dtsch Arztebl Int 2012; 109[27/28]: 484-9)…
Evaluation of Ocular Comfort With ISTA Tears vs Systane
Status: Recruiting,
Condition Summary: Dry Eye Disease